Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Montana Wildhack who wrote (7076)	4/3/2001 3:35:27 PM
From: Joe Krupa	Read Replies (1) \| Respond to of 14101

34,800 so far for Refco Futures (eom)

To: Montana Wildhack who wrote (7076)	4/4/2001 2:32:30 AM
From: twentyfirstcenturyfox	Read Replies (3) \| Respond to of 14101

Wolf - I read the OldMutual report on Provalis. Maybe I'm being pessimistic, but Kwok projects PRO will spend only a half million pounds in 2001 on drug acquisitions. That translates into about half of your estimate for upfront receipts by DMX. I wonder if the upfront receipt could be split over 2 years, ie 2001 and 2002. Comments? We'll know soon enough. I must admit I had a hard time not getting PO'd with the latest financing draw NR. Has Rebecca never heard of a line of credit? My calculation is $6.94/share. When I first read of this (Acqua) deal, I never expected to see DMX selling shares at these prices. Frustrating to think that the timing of news can hurt like this. Don.